Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines

      Purpose: To determine whether curcumin ameliorates acute and chronic radiation skin toxicity and to examine the expression of inflammatory cytokines (interleukin [IL]-1, IL-6, IL-18, IL-1Ra, tumor necrosis factor [TNF]-α, and lymphotoxin-β) or fibrogenic cytokines (transforming growth factor [TGF]-β) during the same acute and chronic phases.
      Methods and Materials: Curcumin was given intragastrically or intraperitoneally to C3H/HeN mice either: 5 days before radiation; 5 days after radiation; or both 5 days before and 5 days after radiation. The cutaneous damage was assessed at 15–21 days (acute) and 90 days (chronic) after a single 50 Gy radiation dose was given to the hind leg. Skin and muscle tissues were collected for measurement of cytokine mRNA.
      Results: Curcumin, administered before or after radiation, markedly reduced acute and chronic skin toxicity in mice (p < 0.05). Additionally, curcumin significantly decreased mRNA expression of early responding cytokines (IL-1 IL-6, IL-18, TNF-α, and lymphotoxin-β) and the fibrogenic cytokine, TGF-β, in cutaneous tissues at 21 days postradiation.
      Conclusion: Curcumin has a protective effect on radiation-induced cutaneous damage in mice, which is characterized by a downregulation of both inflammatory and fibrogenic cytokines in irradiated skin and muscle, particularly in the early phase after radiation. These results may provide the molecular basis for the application of curcumin in clinical radiation therapy.


      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Herskind C.
        • Bamberg M.
        • Rodemann H.P.
        The role of cytokines in the development of normal-tissue reactions after radiotherapy.
        Strahlenther Onkol. 1998; 174: 12-15
        • Hill R.P.
        • Rodemann H.P.
        • Hendry J.H.
        • et al.
        Normal tissue radiobiology.
        Int J Radiat Oncol Biol Phys. 2001; 49: 353-365
        • Riekki R.
        • Jukkola A.
        • Sassi M.L.
        • et al.
        Modulation of skin collagen metabolism by irradiation.
        Br J Dermatol. 2000; 142: 874-880
        • Sassi M.
        • Jukkola A.
        • Riekki R.
        • et al.
        Type I collagen turnover and cross-linking are increased in irradiated skin of breast cancer patients.
        Radiother Oncol. 2001; 58: 317-323
        • Rodemann H.P.
        • Bamberg M.
        Cellular basis of radiation-induced fibrosis.
        Radiother Oncol. 1995; 35: 83-90
        • Rodemann H.P.
        • Binder A.
        • Burger A.
        • et al.
        The underlying cellular mechanism of fibrosis.
        Kidney Int. 1996; 54: S32-S36
        • Varani J.
        • Schuger L.
        • Dame M.K.
        • et al.
        Reduced fibroblast interaction with intact collagen as a mechanism for depressed collagen synthesis in photodamaged skin.
        J Invest Dermatol. 2004; 122: 1471-1479
        • Dimitrijevic-Bussod M.
        • Balzaretti-Maggi V.S.
        • Gadbois D.M.
        Extracellular matrix and radiation G1 cell cycle arrest in human fibroblasts.
        Cancer Res. 1999; 59: 4843-4847
        • Stone H.B.
        • Coleman C.N.
        • Anscher M.S.
        • et al.
        Effects of radiation on normal tissue.
        Lancet Oncol. 2003; 4: 529-536
        • Sivan V.
        • Vozenin-Brotons M.C.
        • Tricaud Y.
        • et al.
        Altered proliferation and differentiation of human epidermis in cases of skin fibrosis after radiotherapy.
        Int J Radiat Oncol Biol Phys. 2002; 53: 385-393
        • Vozenin-Brotons M.C.
        • Gault N.
        • Sivan V.
        • et al.
        Histopathological and cellular studies of a case of cutaneous radiation syndrome after accidental chronic exposure to a cesium source.
        Radiat Res. 1999; 152: 332-337
        • Herskind C.
        • Johansen J.
        • Bentzen S.M.
        • et al.
        Fibroblast differentiation in subcutaneous fibrosis after postmastectomy radiotherapy.
        Acta Oncol. 2000; 39: 383-388
        • Johansen J.
        • Overgaard J.
        • Rose C.
        • et al.
        Cosmetic outcome and breast morbidity in breast-conserving treatment—results from the Danish DBCG-82TM national randomized trial in breast cancer.
        Acta Oncol. 2002; 41: 369-380
        • Delanian S.
        • Porcher R.
        • Rudant J.
        • et al.
        Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis.
        J Clin Oncol. 2005; 23: 8570-8579
        • Okunieff P.
        • Augustine E.
        • Hicks J.E.
        • et al.
        Pentoxifylline in the treatment of radiation-induced fibrosis.
        J Clin Oncol. 2004; 22: 2207-2213
        • Martin M.
        • Delanian S.
        • Sivan V.
        • et al.
        Radiation-induced superficial fibrosis and TGF-alpha 1.
        Cancer Radiother. 2000; 4: 369-384
        • Martin M.
        • Lefaix J.
        • Delanian S.
        TGF-beta1 and radiation fibrosis.
        Int J Radiat Oncol Biol Phys. 2000; 47: 277-290
        • Martinet Y.
        • Menard O.
        • Vaillant P.
        • et al.
        Cytokines in human lung fibrosis.
        Arch Toxicol. 1996; : 127-139
        • Delanian S.
        • Martin M.
        • Bravard A.
        • et al.
        Abnormal phenotype of cultured fibroblasts in human skin with chronic radiotherapy damage.
        Radiother Oncol. 1998; 47: 255-261
        • Ardies C.M.
        Exercise, cachexia, and cancer therapy.
        Nutr Cancer. 2002; 42: 143-157
        • Moore A.H.
        • Olschowka J.A.
        • O’Banion M.K.
        Intraparenchymal administration of interleukin-1beta induces cyclooxygenase-2-mediated expression of membrane- and cytosolic-associated prostaglandin E synthases in mouse brain.
        J Neuroimmunol. 2004; 148: 32-40
        • Moore A.H.
        • Olschowka J.A.
        • Williams J.P.
        • et al.
        Regulation of prostaglandin E2 synthesis after brain irradiation.
        Int J Radiat Oncol Biol Phys. 2005; 62: 267-272
        • al-Majid S.
        • McCarthy D.O.
        Cancer-induced fatigue and skeletal muscle wasting.
        Biol Res Nurs. 2001; 2: 186-197
        • Li J.K.
        • Lin-Shia S.Y.
        Mechanisms of cancer chemoprevention by curcumin.
        Proc Natl Sci Counc Repub China. 2001; B25: 59-66
        • Lim G.P.
        • Chu T.
        • Yang F.
        • et al.
        The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.
        J Neurosci. 2001; 21: 8370-8377
        • Ramsewak R.S.
        • DeWitt D.L.
        • Nair M.G.
        Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa.
        Phytomedicine. 2000; 7: 303-308
        • Natarajan C.
        • Bright J.J.
        Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.
        J Immunol. 2002; 168: 6506-6513
        • Masuda T.
        • Toi Y.
        • Bando H.
        • et al.
        Structural identification of new curcumin dimers and their contribution to the antioxidant mechanism of curcumin.
        J Agric Food Chem. 2002; 50: 2524-2530
        • Hong J.
        • Bose M.
        • Ju J.
        • et al.
        Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives.
        Carcinogenesis. 2004; 25: 1671-1679
        • Thaloor D.
        • Miller K.J.
        • Gephart J.
        • et al.
        Systemic administration of the NF-kappaB inhibitor curcumin stimulates muscle regeneration after traumatic injury.
        Am J Physiol. 1999; 277: C320-C329
        • Thresiamma K.C.
        • George J.
        • Kuttan R.
        Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity.
        Indian J Exp Biol. 1996; 34: 845-847
        • Ding I.
        • Liu W.M.
        • Sun J.Z.
        • et al.
        Comparison and modulation of angiogenic response by FGFs, VEGF and SCF in murine and human fibrosarcomas.
        Comp Biochem Physiol. 2002; 132: 17-25
        • Liang L.
        • Hu D.
        • Liu W.
        • et al.
        Celecoxib reduces skin damage after radiation.
        Am J Clin Oncol. 2003; 26 (2003): S114-S121
        • Literat A.
        • Su F.
        • Norwicki M.
        • et al.
        Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD).
        Life Sci. 2001; 70: 253-267
        • Frautschy S.A.
        • Hu W.
        • Kim P.
        • et al.
        Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology.
        Neurobiol Aging. 2001; 22: 993-1005
        • Huang M.T.
        • Lysz T.
        • Ferraro T.
        • et al.
        Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis.
        Cancer Res. 1991; 51: 813-819
        • Parshad R.
        • Sanford K.K.
        • Price F.M.
        • et al.
        Protective action of plant polyphenols on radiation-induced chromatid breaks in cultured human cells.
        Anticancer Res. 1998; 18: 3263-3266
        • Khopde S.M.
        • Priyadarsini K.I.
        • Guha S.N.
        • et al.
        Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin.
        Biosci Biotechnol Biochem. 2000; 64: 503-509
        • Kapoor S.
        • Priyadarsini K.I.
        Protection of radiation-induced protein damage by curcumin.
        Biophys Chem. 2001; 92: 119-126
        • Choudhary D.
        • Chandra D.
        • Kale R.K.
        Modulation of radioresponse of glyoxalase system by curcumin.
        J Ethnopharmacol. 1999; 64: 1-7
        • Thresiamma K.C.
        • George J.
        • Kuttan R.
        Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity.
        J Exp Clin Cancer Res. 1998; 17: 431-434
        • Venkatesan N.
        Curcumin attenuation of acute Adriamycin myocardial toxicity in rats.
        Br J Pharmacol. 1998; 124: 425-427
        • Nirmala C.
        • Anand S.
        • Puvanakrishnan R.
        Curcumin treatment modulates collagen metabolism in isoproterenol induced myocardial necrosis in rats.
        Mol Cell Biochem. 1999; 197: 31-37
        • Rajakrishnan V.
        • Viswanathan P.
        • Rajasekharan K.N.
        • et al.
        Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage.
        Phytother Res. 1999; 13: 571-574
        • Park E.J.
        • Jeon C.H.
        • Ko G.
        • et al.
        Protective effect of curcumin in rat liver injury induced by carbon tetrachloride.
        J Pharm Pharmacol. 2000; 52: 437-440
        • Punithavathi D.
        • Venkatesan N.
        • Babu M.
        Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats.
        Br J Pharmacol. 2000; 131: 169-172
        • Venkatesan N.
        Pulmonary protective effects of curcumin against paraquat toxicity.
        Life Sci. 2000; 66: L21-L28
        • Venkatesan N.
        • Punithavathi D.
        • Arumugam V.
        Curcumin prevents Adriamycin nephrotoxicity in rats.
        Br J Pharmacol. 2000; 129: 231-234
        • Okada K.
        • Wangpoengtrakul C.
        • Tanaka T.
        • et al.
        Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice.
        J Nutr. 2001; 131: 2090-2095
        • Shoskes D.A.
        Effect of bioflavonoids quercetin and curcumin on ischemic renal injury.
        Transplantation. 1998; 66: 147-152
        • Jones E.A.
        • Shoskes D.A.
        The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair.
        J Urol. 2000; 163: 999-1004
        • Sidhu G.S.
        • Singh A.K.
        • Thaloor D.
        • et al.
        Enhancement of wound healing by curcumin in animals.
        Wound Repair Regen. 1998; 6: 167-177
        • Sidhu G.S.
        • Mani H.
        • Gaddipati J.P.
        • et al.
        Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice.
        Wound Repair Regen. 1999; 7: 362-374
        • Liu A.
        • Lou H.
        • Zhao L.
        • et al.
        Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin.
        J Pharm Biomed Anal. 2006; 40: 720-727
        • Garcea G.
        • Berry D.P.
        • Jones D.J.
        • et al.
        Consumption of the putative chemopreventive agent curcumin by cancer patients.
        Cancer Epidemiol Biomarkers Prev. 2005; 14: 120-125
        • Asai A.
        • Miyazawa T.
        Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma.
        Life Sci. 2000; 67: 2785-2793
        • Bruzell E.M.
        • Morisbak E.
        • Tonnesen H.H.
        Studies on curcumin and curcuminoids. XXIX. Photoinduced cytotoxicity of curcumin in selected aqueous preparations.
        Photochem Photobiol Sci. 2005; 4: 523-530
        • Kumar V.
        • Lewis S.A.
        • Mutalik S.
        • et al.
        Biodegradable microspheres of curcumin for treatment of inflammation.
        Indian J Physiol Pharmacol. 2002; 46: 209-217
        • Sharma R.A.
        • Euden S.A.
        • Platton S.L.
        • et al.
        Phase I clinical trial of oral curcumin.
        Clin Cancer Res. 2004; 10: 6847-6854
        • Sharma R.A.
        • McLelland H.R.
        • Hill K.A.
        • et al.
        Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.
        Clin Cancer Res. 2001; 7: 1894-1900


      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.